Clinical trial
Treatment and Prevention of Severe Anemia in Pregnant Zanzibari Women
NCT00148629 · Cornell University, Other · Completed
Key facts
| NCT number | NCT00148629 |
|---|---|
| Title | Treatment and Prevention of Severe Anemia in Pregnant Zanzibari Women |
| Official title | Preventing Unnecessary Blood Transfusions in Pregnant Women in Africa Through Effective Primary Health Care |
| Lead sponsor | Cornell University, Other |
| Collaborators | Bill and Melinda Gates Foundation UNICEF Johns Hopkins Bloomberg School of Public Health |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Low Birth Weight, Neonatal Mortality |
| Intervention type | Drug |
| Interventions | multivitamin, mebendazole |
| Enrollment | 2,500 |
| Start date | Apr 1, 2004 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Sep 8, 2005 |
| Last update posted | Feb 13, 2026 |
| Countries | Tanzania |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: